3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
5
Prostatic Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
2
Meningioma
2
Glioma
2
Glioblastoma
2
Breast Neoplasms
2
Stage I Prostate Adenocarcinoma AJCC v7
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Resectable Lung Non-Small Cell Carcinoma
1
Pituitary Neoplasms
1
Pancreatic Neoplasms
1
Oligodendroglioma
1
Neurilemmoma
1
Nerve Sheath Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Ion Beam Radiation Therapy for Tumor Patients
1
HER2-positive Breast Cancer
1
Gastroesophageal Junction Adenocarcinoma
1
Clinical Stage I Esophageal Adenocarcinoma AJCC v8
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Carcinoma In Situ
1
Brain Neoplasms
1
Astrocytoma
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
Gemcitabine
113
130-nm albumin-bound paclitaxel
64
Albumin-Bound Paclitaxel
43
Fluorouracil
37
pembrolizumab
35
Magnetic Resonance Spectroscopy
35
Irinotecan
34
Taxes
33
Specimen Handling
33
Leucovorin
33
Oxaliplatin
31
Biopsy
22
Cyclophosphamide
21
Nivolumab
18
Cisplatin
17
fludarabine
16
Radiosurgery
16
Drug Therapy
15
Capecitabine
12
folfirinox
11
durvalumab
11
Radiotherapy
11
Carboplatin
11
Blood Specimen Collection
11
irinotecan sucrosofate
10
Ipilimumab
10
Cetuximab
10
olaparib
9
Standard of Care
9
dehydroftorafur
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pancreatic Neoplasms
×
Protons
×
1 year
×
Clear all
NCT04894643
2026-03-20
PARC
EBG MedAustron GmbH
Phase NA
Recruiting
10 enrolled